AtriCure [ATRC] vs Becton, Dickinson [BDX] Detailed Stock Comparison

AtriCure Inc.

NASDAQ
Loading...

Becton, Dickinson and Company

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: AtriCure Inc. wins in 3 metrics, Becton, Dickinson and Company wins in 17 metrics, with 0 ties. Becton, Dickinson and Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric AtriCure Inc. Becton, Dickinson and Company Better
P/E Ratio (TTM) -117.54 25.40 Becton, Dickinson and Company
Price-to-Book Ratio 2.77 1.75 Becton, Dickinson and Company
Debt-to-Equity Ratio 15.54 77.28 AtriCure Inc.
PEG Ratio 1.05 0.92 Becton, Dickinson and Company
EV/EBITDA 114.79 10.49 Becton, Dickinson and Company
Profit Margin (TTM) -2.14% 8.01% Becton, Dickinson and Company
Operating Margin (TTM) 1.77% 13.35% Becton, Dickinson and Company
EBITDA Margin (TTM) 1.77% 13.35% Becton, Dickinson and Company
Return on Equity -2.40% 6.96% Becton, Dickinson and Company
Return on Assets (TTM) -0.94% 4.08% Becton, Dickinson and Company
Free Cash Flow (TTM) $42.28M $2.67B Becton, Dickinson and Company
Dividend Yield N/A 2.56% N/A
1-Year Return -19.96% 8.43% Becton, Dickinson and Company
Price-to-Sales Ratio (TTM) 2.59 2.57 Becton, Dickinson and Company
Enterprise Value $1.27B $63.40B Becton, Dickinson and Company
EV/Revenue Ratio 2.38 2.89 AtriCure Inc.
Gross Profit Margin (TTM) 74.97% 45.91% AtriCure Inc.
Revenue per Share (TTM) $11 $76 Becton, Dickinson and Company
Earnings per Share (Diluted) $-0.24 $6.13 Becton, Dickinson and Company
Beta (Stock Volatility) 1.43 0.35 Becton, Dickinson and Company
Short % of Float 7.28% 3.78% Becton, Dickinson and Company

AtriCure Inc. vs Becton, Dickinson and Company Stock Performance Analysis

Loading Price Chart...

ATRC
BDX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
AtriCure Inc.1.28%-10.24%-10.15%-16.39%-26.76%-34.15%
Becton, Dickinson and Company0.81%-2.25%-1.28%-18.19%-3.55%-5.76%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
AtriCure Inc.-19.96%-41.04%-62.90%85.58%92.55%278.01%
Becton, Dickinson and Company8.43%-25.68%-20.29%13.34%123.65%215.10%

Performance & Financial Health Analysis: AtriCure Inc. vs Becton, Dickinson and Company

MetricATRCBDX
Market Information
Market Cap i$1.43B$56.10B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i807,5992,759,250
90 Day Avg. Volume i650,2002,521,130
Last Close$26.19$145.60
52 Week Range$25.37 - $43.18$127.59 - $187.35
% from 52W High-39.35%-22.28%
All-Time High$89.18 (Nov 01, 2021)$287.32 (Jul 24, 2023)
% from All-Time High-70.63%-49.32%
Growth Metrics
Quarterly Revenue Growth0.13%0.02%
Quarterly Earnings Growth0.13%0.26%
Financial Health
Profit Margin (TTM) i-0.02%0.08%
Operating Margin (TTM) i0.02%0.13%
Return on Equity (TTM) i-0.02%0.07%
Debt to Equity (MRQ) i15.5477.28
Cash & Liquidity
Book Value per Share (MRQ)$9.88$88.79
Cash per Share (MRQ)$3.36$2.64
Operating Cash Flow (TTM) i$57.33M$3.39B
Levered Free Cash Flow (TTM) i$38.94M$3.11B
Dividends
Last 12-Month Dividend Yield iN/A2.56%
Last 12-Month Dividend iN/A$4.18

Valuation & Enterprise Metrics Analysis: AtriCure Inc. vs Becton, Dickinson and Company

MetricATRC (Apr 24, 2026)BDX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-117.5425.40
Forward P/E i74.0511.53
PEG Ratio i1.050.92
Price to Sales (TTM) i2.592.57
Price to Book (MRQ) i2.771.75
Market Capitalization
Market Capitalization i$1.43B$56.10B
Enterprise Value i$1.27B$63.40B
Enterprise Value Metrics
Enterprise to Revenue i2.382.89
Enterprise to EBITDA i114.7910.49
Risk & Other Metrics
Beta i1.430.35
Book Value per Share (MRQ) i$9.88$88.79

Financial Statements Comparison: AtriCure Inc. vs Becton, Dickinson and Company

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricATRC (2025)BDX (2025)
Revenue/Sales i534.53M21.84B
Cost of Goods Sold i133.75M11.92B
COGS % of Revenue i25.0%54.6%
Gross Profit i400.78M9.93B
Gross Margin i75.0%45.4%
Research & Development i99.21M1.27B
Operating Income (EBIT) i-9.45M2.99B
Operating Margin i-1.8%13.7%
EBITDA i16.25M5.42B
EBITDA Margin i3.0%24.8%
Pre-Tax Income i-10.16M1.88B
Pre-Tax Income % of Revenue i-1.9%8.6%
Income Tax i1.29M203.00M
Income Tax % of Revenue i0.2%0.9%
Net Income (Profit) i-11.45M1.68B
Profit Margin i-2.1%7.7%

Balance Sheet & Liquidity Metrics

MetricATRC (2025)BDX (2025)
Cash & Equivalents i167.43M641.00M
Total Current Assets i322.52M9.26B
Total Current Assets % of Revenue i60.3%42.4%
Total Current Liabilities i81.52M8.31B
Total Current Liabilities % of Revenue i15.3%38.1%
Long-Term Debt i73.38M17.62B
Long-Term Debt % of Revenue i13.7%80.7%
Total Shareholders Equity i491.94M25.39B
Retained Earnings i-413.20M16.62B
Retained Earnings % of Revenue i-77.3%76.1%
Property, Plant & Equipment i34.26M0

Cash Flow Statement Comparison

MetricATRC (2025)BDX (2025)
Operating Cash Flow i52.59M3.68B
Operating Cash Flow % of Revenue i9.8%16.9%
Capital Expenditures i-9.05MN/A
Free Cash Flow i42.28M2.67B
FCF Margin i7.9%12.2%
Debt Repayment i-1.20M-1.79B
Common Stock Repurchase i-11.16MN/A

Short Interest & Institutional Ownership Analysis

MetricATRCBDX
Shares Short i3.54M9.49M
Short Ratio i6.293.92
Short % of Float i7.28%3.78%
Shares Outstanding i49.79M284.74M
Float Shares i47.79M283.99M
% Held by Insiders i3.77%0.40%
% Held by Institutions i99.25%96.58%
% Held by Public i-3.02%3.02%

Dividend Analysis & Yield Comparison: AtriCure Inc. vs Becton, Dickinson and Company

MetricATRCBDX
Last 12-Month Dividend iN/A$4.18
Last 12-Month Dividend Yield iN/A2.56%
3-Year Avg Annual Dividend iN/A$3.96
3-Year Avg Dividend Yield iN/A0.58%
3-Year Total Dividends iN/A$11.88
Ex-Dividend DateN/AMar 10, 2026